Today is shaping up negative for Silence Therapeutics plc ( NASDAQ:SLN ) shareholders, with the analysts delivering a... LONDON, March 05, 2025--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or ...

Stay updated on market trends for SLN. Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.

This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

AN eye clinic is now open at the Metoreia Health Centre in the National Capital District.